Skip to main content
. 2017 Dec 1;7(4):125–132. doi: 10.1089/jcr.2017.0025

Table 3.

Statistical Analysis of the Pharmacokinetic Parameters for Caffeine

          90% CI for the ratio (test:reference)  
Parameter (unit) Treatment n Geometric least squares means Ratio of geometric least squares means (test:reference) Lower Upper p
DN AUC0-t (h·ng/mL/mg) Caffeinated chewing gum (test)
Caffeinated beverage (reference)
15
16
172
160

1.07

1.04

1.11
 
DN AUC0-∞ (h·ng/mL/mg) Caffeinated chewing gum (test)
Caffeinated beverage (reference)
15
16
183
168

1.09

1.05

1.13
 
DN Cmax (ng/mL/mg) Caffeinated chewing gum (test)
Caffeinated beverage (reference)
15
16
28.7
25.7

1.12

1.04

1.20
 
tmax (h)a Caffeinated chewing gum (test) 15 0.67        
  Caffeinated beverage (reference) 15 0.58 −0.08 −0.17 0.08 0.3308
ka (h−1)a Caffeinated chewing gum (test) 15 2.36        
  Caffeinated beverage (reference) 15 2.60 0.33 −0.36 1.15 0.3894

One subject was excluded from chewing gum treatment since the quantifiable predose value was >5% of Cmax value. Only paired data were presented and statistically analyzed for tmax and ka. Least-square means and 90% CI are based on a linear mixed-effects model with treatment as a fixed effect and subject as a random effect. The ratio and corresponding confidence limits are back-transformed from the original difference and confidence.

a

Medians, median of differences, approximate 90% confidence interval and p-value from the Wilcoxon signed-rank test are presented.

DN AUC0-t, dose-normalized area under the concentration–time curve (AUC) from hour 0 to the last measureable concentration; DN AUC0-∞, dose-normalized AUC extrapolated to infinity; DN Cmax, dose-normalized maximum observed concentration; tmax, time of the maximum observed concentration; ka, absorption rate constant; CI, confidence interval; n, number of subjects.